Cargando…
Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments
In this study we utilized data on patient responses to guided treatments, and we evaluated their benefit for a non-small cell lung cancer cohort. The recommended therapies used were predicted using tumor molecular profiles that involved a range of biomarkers but primarily used immunohistochemistry m...
Autores principales: | Alifrangis, Costi, Carter, Philip, Cereser, Biancastella, Chandrasinghe, Pramodh, Belluz, Lisa Del Bel, Lim, Eric, Moderau, Nina, Poyia, Fotini, Tabassum, Neha, Zhang, Hua, Krell, Jonathan, Stebbing, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849175/ https://www.ncbi.nlm.nih.gov/pubmed/29560111 http://dx.doi.org/10.18632/oncotarget.24375 |
Ejemplares similares
-
Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans
por: Carter, Philip, et al.
Publicado: (2018) -
The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas
por: Carter, Philip, et al.
Publicado: (2018) -
Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas
por: Carter, Philip, et al.
Publicado: (2018) -
Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy
por: Carter, Philip, et al.
Publicado: (2017) -
Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy
por: Carter, Philip, et al.
Publicado: (2018)